Intuitive Surgical, Inc. $ISRG Stock Acquired by WoodTrust Financial Corp

WoodTrust Financial Corp raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 40.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,870 shares of the medical equipment provider’s stock after acquiring an additional 1,700 shares during the quarter. WoodTrust Financial Corp’s holdings in Intuitive Surgical were worth $2,387,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in ISRG. Motiv8 Investments LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth about $34,000. Main Street Group LTD purchased a new position in Intuitive Surgical in the 1st quarter worth approximately $30,000. North Point Portfolio Managers Corp OH purchased a new position in Intuitive Surgical in the 3rd quarter worth approximately $27,000. Vermillion Wealth Management Inc. boosted its stake in Intuitive Surgical by 58.1% in the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after purchasing an additional 25 shares during the period. Finally, Evergreen Advisors LLC bought a new position in Intuitive Surgical in the 1st quarter worth approximately $35,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

ISRG stock traded up $10.41 during trading on Friday, hitting $425.82. 779,043 shares of the company’s stock traded hands, compared to its average volume of 2,414,883. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88. The stock has a market capitalization of $150.43 billion, a price-to-earnings ratio of 48.76, a P/E/G ratio of 3.13 and a beta of 1.46. The business has a fifty day simple moving average of $384.95 and a 200 day simple moving average of $411.17.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. The firm had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.81 EPS. Research analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Barclays upgraded Intuitive Surgical to “strong buy” after initiating coverage with an overweight view. The firm reportedly considers ISRG a high-quality medical-equipment company, offering a positive catalyst for investor sentiment. Intuitive Surgical upgraded at Barclays
• Positive Sentiment: Piper Sandler also initiated or reiterated a buy view on ISRG, adding to the recent concentration of bullish sell-side coverage. Intuitive Surgical gets a buy from Piper Sandler
• Positive Sentiment: The da Vinci SP single-port platform is gaining traction. Rising procedures, utilization and system placements, along with expanding medical indications and international adoption, could create another significant recurring-revenue growth franchise for Intuitive Surgical. Can ISRG’s Single-Port Platform Become the Next Billion-Dollar Franchise?
• Neutral Sentiment: Analysts remain broadly optimistic, but the average brokerage recommendation may be an imperfect signal. Commentary cautions that sell-side ratings can be overly positive, leaving investors to assess ISRG’s premium valuation and upcoming earnings execution independently. Is Intuitive Surgical a Buy as Wall Street Analysts Look Optimistic?
• Negative Sentiment: Competitive pressure remains a key concern. Jim Cramer questioned the investment case because companies including Johnson & Johnson are pursuing the robotic-surgery market, potentially challenging ISRG’s leadership and valuation. Intuitive Surgical and JNJ Give Jim Cramer More Than Valuation to Consider

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on ISRG. BMO Capital Markets reiterated an “outperform” rating on shares of Intuitive Surgical in a research report on Monday, July 20th. Leerink Partners dropped their target price on shares of Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating for the company in a research report on Friday, July 17th. JPMorgan Chase & Co. cut their target price on shares of Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating for the company in a research note on Friday, July 17th. Robert W. Baird reduced their price target on shares of Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, July 17th. Finally, UBS Group started coverage on shares of Intuitive Surgical in a research note on Tuesday, July 28th. They issued a “neutral” rating and a $500.00 price target on the stock. One investment analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $502.53.

Insider Buying and Selling

In other Intuitive Surgical news, Director Gary Guthart sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the sale, the director directly owned 1,245,679 shares of the company’s stock, valued at $498,271,600. The trade was a 0.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the sale, the executive vice president directly owned 5,320 shares of the company’s stock, valued at $2,016,280. The trade was a 6.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 12,370 shares of company stock valued at $4,891,989 in the last quarter. 0.60% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.